TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8548117

Group type: EXPERIMENTAL
Intervention: Maintaining sinus rhythm through chronic administration of antiarrhythmic agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlling ventricular rate and chronic anticoagulation
Number of subjects: 0
Study: 1963022

Group type: EXPERIMENTAL
Intervention: Enoxaparin 60 mg
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg
Number of subjects: 892

Group type: COMPARATOR
Intervention: Unfractionated heparin 5000 IU tds
Number of subjects: 892
Study: 7221357

Group type: EXPERIMENTAL
Intervention: 2.4 g of bacampicillin plus 1.0 g of probenecid
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 1.6 g of bacampicillin plus 1.0 g of probenecid
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 3.5 g of ampicillin plus 1.0 g of probenecid
Number of subjects: 228
Study: 31331240

Group type: EXPERIMENTAL
Intervention: Standardized protocol for postoperative care (4- to 6-day intubation, determined choice, dosage, and duration of sedating medications)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standardized protocol for postoperative care
Number of subjects: 16

Group type: COMPARATOR
Intervention: Preprotocol management (case-by-case)
Number of subjects: 16
Study: 30012355

Group type: EXPERIMENTAL
Intervention: High-dose oral cholecalciferol (100,000 IU vitamin D3 at baseline and week 2)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 26184499

Group type: EXPERIMENTAL
Intervention: Coping-Together intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Minimal Ethical Care (MEC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Coping-Together
Number of subjects: 42
Study: 24169195

Group type: COMPARATOR
Intervention: Mesh plug repair
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Lichtenstein's operation
Number of subjects: 594
Study: 22687487

Group type: EXPERIMENTAL
Intervention: Escitalopram monotherapy plus placebo
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Bupropion SR + escitalopram
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR + mirtazapine
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Combination treatments (bupropion SR + escitalopram or venlafaxine XR + mirtazapine)
Number of subjects: 663

Group type: COMPARATOR
Intervention: SSRI monotherapy
Number of subjects: 663
Study: 19625712

Group type: EXPERIMENTAL
Intervention: Standard-dose peginterferon alfa‐2b (1.5 microg/kg/week) + ribavirin (800-1400 mg/day)
Number of subjects: 3070

Group type: EXPERIMENTAL
Intervention: Low-dose peginterferon alfa‐2b (1.0 microg/kg/week) + ribavirin (800-1400 mg/day)
Number of subjects: 3070

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a (180 microg/week) + ribavirin (1000-1200 mg/day)
Number of subjects: 3070

Group type: COMPARATOR
Intervention: Standard-dose peginterferon alfa‐2b
Number of subjects: 3070

Group type: COMPARATOR
Intervention: Low-dose peginterferon alfa‐2b
Number of subjects: 3070

Group type: COMPARATOR
Intervention: Peginterferon alfa‐2a
Number of subjects: 3070

Group type: EXPERIMENTAL
Intervention: Patients with undetectable HCV RNA levels at treatment weeks 4 and 12
Number of subjects: 3070
Study: 17452491

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection with 4 sessions of occupational therapy over 4 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Occupational therapy alone
Number of subjects: 43
Study: 15157685

Group type: EXPERIMENTAL
Intervention: Tramadol/Acetaminophen (APAP) 75 mg/650 mg
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study: 11593710

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion of droperidol 10 mg in 48 hours
Number of subjects: 145

Group type: COMPARATOR
Intervention: Bolus doses of droperidol 2.5 mg
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 9689301

Group type: EXPERIMENTAL
Intervention: Ammonium solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8607936

Group type: EXPERIMENTAL
Intervention: IVIg 500 mg/kg/month
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 95
Study: 2569887

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1067153

Group type: EXPERIMENTAL
Intervention: Professional mechanical toothcleansing every 2 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 78
Study: 30691404

Group type: EXPERIMENTAL
Intervention: Interactive cognitive-motor training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Active control (passive information activity)
Number of subjects: 62
Study: 28137517

Group type: EXPERIMENTAL
Intervention: Turkish classical music therapy for 30 minutes daily for 7 days (5 days before and 2 days after labor)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Turkish classical music therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine care and 30 minutes of bed rest daily
Number of subjects: 70
Study: 26412309

Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) procedure, Usability study
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) procedure, Registry
Number of subjects: 273
Study: 23172402

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) method, N=11, twelve sessions
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Treadmill training with partial body-weight support (TPBWS), N=12, twelve sessions
Number of subjects: 23
Study: 21632816

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control group (Conventional insulin therapy - CIT)
Number of subjects: 369
Study: 20137621

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) 5 mg/kg body weight at 0, 2, and 6 weeks, followed by maintenance therapy every 8 weeks.
Number of subjects: 8
Study: 16961944

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 56
Study: 14998050

Group type: EXPERIMENTAL
Intervention: Prototype power toothbrush (Crest SpinBrush Pro Whitening)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Positive control power toothbrush (Sonicare Personal 4100)
Number of subjects: 20
Study: 11242725

Group type: EXPERIMENTAL
Intervention: DentiPatch (20% lidocaine)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Topical anesthetic gel (20% benzocaine)
Number of subjects: 32
Study: 9133513

Group type: EXPERIMENTAL
Intervention: Angina-guided drug therapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Ischemia-guided drug therapy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Revascularization by angioplasty or bypass surgery
Number of subjects: 558
Study: 7595182

Group type: EXPERIMENTAL
Intervention: gemfibrozil 1200 mg day‐1
Number of subjects: 20
Study: 2213261

Group type: EXPERIMENTAL
Intervention: Fiberoptic blanket (Wallaby Phototherapy System)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard phototherapy unit
Number of subjects: 42
Study: 156916

Group type: EXPERIMENTAL
Intervention: Fenoterol (0.5 mg, inhalation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.25 mg, inhalation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theophylline (240 mg, intravenous)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disodium cromoglicicum (20 mg, before tests)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated probands
Number of subjects: 0
Study: 31546056

Group type: EXPERIMENTAL
Intervention: Mesalazine treatment
Number of subjects: 817
Study: 30550498

Group type: EXPERIMENTAL
Intervention: Symptom management patient education
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 169
Study: 28387016

Group type: EXPERIMENTAL
Intervention: SPG neuromodulation
Number of subjects: 300
Study: 28912892

Group type: EXPERIMENTAL
Intervention: Simultaneous fingerprint (FP) and high‐wavenumber (HW) fiber‐optic Raman spectroscopy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Fingerprint (FP) Raman technique alone
Number of subjects: 95

Group type: COMPARATOR
Intervention: High‐wavenumber (HW) Raman technique alone
Number of subjects: 95
Study: 24112947

Group type: EXPERIMENTAL
Intervention: Social skills training in addition to TAU
Number of subjects: 119

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 119
Study: 21842428

Group type: EXPERIMENTAL
Intervention: DepoFoam bupivacaine 120 mg
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 19282306

Group type: EXPERIMENTAL
Intervention: Transluminal endoscopic necrosectomy
Number of subjects: 93
Study: 17804986

Group type: EXPERIMENTAL
Intervention: Bitemporal ECT
Number of subjects: 489

Group type: COMPARATOR
Intervention: Nortriptyline plus lithium (continuation pharmacotherapy)
Number of subjects: 489

Group type: COMPARATOR
Intervention: No melancholic features
Number of subjects: 489
Study: 15550321

Group type: EXPERIMENTAL
Intervention: Acupuncture needle manipulation with varying amounts of rotation, downward and upward movement.
Number of subjects: 12
Study: 11517739

Group type: EXPERIMENTAL
Intervention: Antibodies to tumor necrosis factor-alpha (anti-TNF-a)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Antibodies to interferon-gamma (anti-INF-g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8866937

Group type: EXPERIMENTAL
Intervention: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 100 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 18
Study: 1323809

Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide/vincristine (CEV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide/vincristine (Control)
Number of subjects: 0
Study: 6209513

Group type: EXPERIMENTAL
Intervention: IVGG
Number of subjects: 85

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 85
Study: 30980923

Group type: EXPERIMENTAL
Intervention: 16 weeks of moderate to high-intensity physical exercise
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 16 weeks of moderate to high-intensity physical exercise in ε4 carriers
Number of subjects: 198
Study: 28784273

Group type: EXPERIMENTAL
Intervention: EnligHTN catheter with 4 ablated spots
Number of subjects: 112

Group type: COMPARATOR
Intervention: Flexability catheter with 4 ablated spots
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: EnligHTN catheter with 20 ablated spots
Number of subjects: 112

Group type: COMPARATOR
Intervention: Flexability catheter with 20 ablated spots
Number of subjects: 112
Study: 26506070

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxandrolone orally twice daily for 24 months
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 23912852

Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ) scores <25
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ) scores >75
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: Lower KCCQ scores
Number of subjects: 1465
Study: 22067612

Group type: EXPERIMENTAL
Intervention: Yoghurts containing microencapsulated L. reuteri NCIMB 30242
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo yoghurts
Number of subjects: 114
Study: 18629529

Group type: EXPERIMENTAL
Intervention: E (3) - Epidural infusion initiated 3 min after spinal induction
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: E (30) - Epidural infusion initiated 30 min after spinal induction
Number of subjects: 144

Group type: COMPARATOR
Intervention: E (60) - Epidural infusion initiated 60 min after spinal induction
Number of subjects: 144

Group type: COMPARATOR
Intervention: E (90) - Epidural infusion initiated 90 min after spinal induction
Number of subjects: 144
Study: 17932348

Group type: EXPERIMENTAL
Intervention: High plasma carotenoid concentrations
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Dietary lycopene
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Dietary lutein/zeaxanthin
Number of subjects: 207
Study: 15232677

Group type: EXPERIMENTAL
Intervention: Steroid regimen (prednisone for 4 months)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Steroid-free regimen
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both groups (steroid-free and steroids)
Number of subjects: 119
Study: 12190655

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (220 micro g twice daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9854806

Group type: EXPERIMENTAL
Intervention: Easy secondary task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Difficult secondary task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Females under central executive pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Males under central executive pressure
Number of subjects: 0
Study: 7796709

Group type: EXPERIMENTAL
Intervention: Fluconazole suspension (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fluconazole capsule (100 mg)
Number of subjects: 12
Study: 2209876

Group type: EXPERIMENTAL
Intervention: Oral micronized estradiol (E2), 2 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (Es), 5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6451440

Group type: EXPERIMENTAL
Intervention: 5 hour program of activities planned to enable the children to perceive and experience the needs of handicapped people, including stimulations, interactions with handicapped people, and discussions.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (received a pretest measure of perceptions of handicapped people)
Number of subjects: 74
Study: 31427859

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - low-volume (10 x 60 s at 90% of maximal aerobic velocity interspaced by 60 s at 30% of MAV)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE) - 20 min at 70% of maximum heart rate
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no exercise) - 25 min in a seated position
Number of subjects: 17
Study: 28236335

Group type: EXPERIMENTAL
Intervention: Intercept pathogen-reduction technology
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Mirasol pathogen-reduction technology
Number of subjects: 424

Group type: COMPARATOR
Intervention: Standard platelets (control)
Number of subjects: 424
Study: 25479112

Group type: EXPERIMENTAL
Intervention: Glidescope video laryngoscopy
Number of subjects: 117

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 117
Study: 25699348

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 60
Study: 21087238

Group type: EXPERIMENTAL
Intervention: Neuronox
Number of subjects: 119

Group type: COMPARATOR
Intervention: BOTOX
Number of subjects: 119
Study: 19023897

Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ in active CD
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ in active UC
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: IVRS administration of SIBDQ (first vs second administration)
Number of subjects: 64
Study: 17517761

Group type: EXPERIMENTAL
Intervention: Liquid based cytology
Number of subjects: 45174

Group type: COMPARATOR
Intervention: Conventional cytology
Number of subjects: 45174
Study: 15489585

Group type: EXPERIMENTAL
Intervention: Interferon + ribavirin
Number of subjects: 163

Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 163
Study: 11403532

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs), specifically esomeprazole at 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: H2-receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of proton pump inhibitors
Number of subjects: 0
Study: 9661803

Group type: EXPERIMENTAL
Intervention: Temocapril, 2 to 4 mg once daily for 12 months
Number of subjects: 63

Group type: COMPARATOR
Intervention: CCBs (nitrendipine, nisoldipine, or amlodipine) continued for 12 months
Number of subjects: 63
Study: 8146105

Group type: EXPERIMENTAL
Intervention: 414 mg nitrate + nitrite and 23 mg vitamin C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 412 mg nitrate + nitrite and 177 mg vitamin C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 23 mg nitrate + nitrite and 39 mg vitamin C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 21 mg nitrate + nitrite and 193 mg vitamin C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increased intake of vitamin C at either level of nitrate + nitrite intake
Number of subjects: 12
Study: 2438222

Group type: EXPERIMENTAL
Intervention: PVeBV (cisplatin, vinblastine, bleomycin, VP-16)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PVeB (cisplatin, vinblastine, bleomycin)
Number of subjects: 0
Study: 31823047

Group type: EXPERIMENTAL
Intervention: Laparoscopic spleen-preserving D2 total gastrectomy (LSTG)
Number of subjects: 242
Study: 30336390

Group type: EXPERIMENTAL
Intervention: Cannabis use 12x/month or more during treatment
Number of subjects: 1205

Group type: COMPARATOR
Intervention: Cannabis abstinence
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Cannabis use (1x/month, 1-2x/month, 4-8x/month)
Number of subjects: 1205
Study: 28699427

Group type: EXPERIMENTAL
Intervention: Treatment to reinstate euthyroidism
Number of subjects: 10
Study: 25053508

Group type: EXPERIMENTAL
Intervention: Non-packing
Number of subjects: 14

Group type: COMPARATOR
Intervention: Packing
Number of subjects: 14
Study: 22665103

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement (QI) intervention including educational materials for clinicians, reminders, algorithms, and case manager training
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement (QI) intervention
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Control group (routine practice)
Number of subjects: 1150
Study: 20485969

Group type: EXPERIMENTAL
Intervention: ProTaper group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: K3 group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mtwo group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 17368342

Group type: EXPERIMENTAL
Intervention: 17% EDTA with ultrasonics (Group C)
Number of subjects: 75

Group type: COMPARATOR
Intervention: 17% EDTA (Group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Smear Clear (Group D)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Smear Clear with ultrasonics (Group E)
Number of subjects: 75
Study: 15698513

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) co-therapy for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chronic COX-2 therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chronic NSAID therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 11999607

Group type: EXPERIMENTAL
Intervention: Inhalation anaesthesia with desflurane or sevoflurane
Number of subjects: 102

Group type: COMPARATOR
Intervention: Propofol administered by target controlled infusion
Number of subjects: 102
Study: 9674667

Group type: EXPERIMENTAL
Intervention: Composite compliance index (unweighted)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Composite compliance index (weighted)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Composite compliance index (statistically weighted)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Urinary isoniazid metabolite testing
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Clinic attendance
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Self-report
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Understanding of the regimen, study arm, subsequent follow-up, tuberculosis status, and urine spot-check result
Number of subjects: 2736
Study: 10155331

Group type: EXPERIMENTAL
Intervention: Epoetin 6000U weekly for 2 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin 9000U weekly for 2 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin 12000U weekly for 2 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin 6000U and 9000U for nonresponders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sensitivity analysis on drug administration cost
Number of subjects: 0
Study: 2664718

Group type: COMPARATOR
Intervention: Nonmechanically assisted relaxation techniques
Number of subjects: 48

Group type: COMPARATOR
Intervention: Benson's relaxation technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Other relaxation treatments
Number of subjects: 48
Study: 195709

Group type: EXPERIMENTAL
Intervention: Radiotherapy with chemotherapy
Number of subjects: 345

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 345
Study: 31553203

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose, 90 mg twice daily thereafter)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose, 75 mg daily thereafter)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 800

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 800
Study: 29450738

Group type: EXPERIMENTAL
Intervention: Articaine (4%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bupivacaine (0.5%)
Number of subjects: 50
Study: 27586537

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (GP) MDI 18, 9, 4.6, and 2.4 μg, twice daily (BID)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (GP) MDI 18 μg, twice daily (BID)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo MDI, twice daily (BID)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Open-label tiotropium dry powder inhaler 18 μg, once daily (QD)
Number of subjects: 120
Study: 25392204

Group type: EXPERIMENTAL
Intervention: Discussion about HIV with others
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age group 24-28 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age group 29-32 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gender (Men)
Number of subjects: 0